Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studies.

por Ghosh, A. K., Mellor, M., Prendiville, J., Thatcher, N.
Publicado 1990

A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.

por Anderson, H., Hopwood, P., Prendiville, J., Radford, J. A., Thatcher, N., Ashcroft, L.
Publicado 1993

Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.

por Prendiville, J., McGown, A. T., Gescher, A., Dickson, A. J., Courage, C., Pettit, G. R., Crowther, D., Fox, B. W.
Publicado 1994

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

por Jayson, G. C., Crowther, D., Prendiville, J., McGown, A. T., Scheid, C., Stern, P., Young, R., Brenchley, P., Chang, J., Owens, S.
Publicado 1995

A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

por Prendiville, J., Crowther, D., Thatcher, N., Woll, P. J., Fox, B. W., McGown, A., Testa, N., Stern, P., McDermott, R., Potter, M.
Publicado 1993

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

por Paz-Ares, L, Ross, H, O'Brien, M, Riviere, A, Gatzemeier, U, Von Pawel, J, Kaukel, E, Freitag, L, Digel, W, Bischoff, H, García-Campelo, R, Iannotti, N, Reiterer, P, Bover, I, Prendiville, J, Eisenfeld, A J, Oldham, F B, Bandstra, B, Singer, J W, Bonomi, P
Publicado 2008